Minnesota Clinical Trials

Recruiting studies in Minnesota

• A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
  NCT07088068PHASE3SanofiType 1 Diabetes MellitusRochester, MN
• A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
  NCT07549321PHASE2, PHASE3Renaissance Pharma Ltd.High-Risk NeuroblastomaMinneapolis, MN
• A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
  NCT07335588PHASE3LEO PharmaLichen SclerosusRochester, MN
• A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
  NCT07823608PHASE3PfizerApneaMaplewood, MN
• The ED-AWARENESS-2 Trial
  NCT05534243NAWashington University School of MedicineAwarenessMinneapolis, MN
• A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
  NCT06667700PHASE3Merck Sharp & Dohme LLCCoronavirus Disease (COVID-19)Mankato, MN
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerMaplewood, MN
• A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
  NCT05947851PHASE3Merck Sharp & Dohme LLCLeukemia, Lymphocytic, Chronic, B-CellMarshall, MN
• Feasibility of Identifying Brain Mechanisms of Qigong and Behavioral Outcomes After Qigong Practice in People With Chronic Low Back Pain
  NCT04164225NAUniversity of MinnesotaLow Back PainMinneapolis, MN
• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801PHASE3Merck Sharp & Dohme LLCCrohn's DiseaseRochester, MN
• A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
  NCT07366034PHASE3Boehringer IngelheimFibrosing Interstitial Lung DiseaseMinneapolis, MN
• A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
  NCT06293053PHASE3SanofiPrurigo NodularisEagan, MN

See all 2,008 recruiting trials →

Clinical trials by Minnesota metro

• Minneapolis
• Rochester

Popular conditions in Minnesota

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Minnesota?

Corterve aggregates actively recruiting clinical trials with sites in Minnesota from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Minnesota free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Minnesota?

Minnesota research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.